54
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Plasma Kinetics and Biliary Excretion of Colchicine in Patients with Chronic Liver Disease after Oral Administration of a Single Dose and after Long-Term Treatment

, , , , , , , & show all
Pages 346-351 | Received 11 Jun 1993, Accepted 21 Sep 1993, Published online: 08 Jul 2009
 

Abstract

Rudi J. Raedsch R, Gerteis C. Schlenker T, Plachky J. Walter-Sack I, Sabouraud A, Scherrmann JM, Kommerell B. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment. Scand J Gastroenterol 1994; 29:346-351.

Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease were evaluated after oral administration of a single dose and after long-term treatment. A single oral dose of 1 mg colchicine led to a mean peak concentration of 3.60 ± 1.04 ng/ml at a peak time of 2.16 ± 0.34 h and a mean area under the plasma concentration time curve, extrapolated from time 0 to infinity, of 24.90 ± 8.47 ng h/ml. Comparable values were obtained after repeated administration. Distribution half-life was 2.83 ± 0.74 h, and terminal plasma elimination half-life was 9.81 ± 2.08 h; the mean apparent volume of distribution and the mean apparent plasma clearance were 1448 ± 4061 and 175.3 ± 47.61/h. respectively. Colchicine concentrations in bile (2025 ± 1368 ng/ml) were clearly higher than in plasma. Long-term treatment with colchicine (1 mg/day) in patients with various stages of primary biliary cirrhosis (PBC) was associated with colchicine concentrations varying from <0.15 to 2.0 ng/ml, with a slight tendency to higher concentrations in PBC stages III–IV than I–II. Although about 20% of colchicine is excreted in bile within 24 h, accumulation of colchicine may appear only in patients with advanced liver disease and cholestasis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.